Latest news

The Biotechnology Business Institute closes the 5th edition of the Scientific MBA in Lifesciences with a great success and four projects developing drug candidates.

Four drug candidates targeting three indications, Breast Cancer, Chron’s Syndrome and NASH (nonalcoholic steatohepatitis), were presented by our students in the closing ceremony of the Scientific MBA’s as a result of a year developing different intellectual properties for potential new treatments

The Biotechnology Business Institute signs a strategic collaboration agreement with IRB Barcelona, the Fundació Bosch i Gimpera and UPF, promoted by UPF Ventures, in a new educational model for drug discovery and technology transfer

The Biotechnology Business Institute (BBI) incorporates Discover & Transfer to the programs, where the students will be working with real drug candidates of these three institutions.

The Biotechnology Business Institute finishes a new master’s edition under the first year of the Discover & Transfer educational agreement

Last week we concluded the master’s edition 2017-2018. After nine months of hard work, board of professors, students and managing directors of the Biotechnology Business Institute joined together the presentation of the final projects in the framework of the first year of the educational agreement Discover & Transfer.

"We need to understand the world as a unique hub, innovation can be in any good university of the world"

Today I have the pleasure of introducing Juan R. Garcia, Chief Executive Officer and Founder of the Biotechnology Business Institute, in Barcelona, and BioSeed Capital in the United Kingdom. He spent the initial part of his career in the laboratory as a researcher and has since become an entrepreneur.